Cerebrolysin

From WikiMD's WELLNESSPEDIA

Cerebrolysin is a peptide preparation derived from pig brains. It is often used as a treatment for Alzheimer's disease, stroke, and other neurological disorders.

Composition[edit]

Cerebrolysin is composed of free amino acids and low-molecular-weight peptides. The exact composition varies, but it typically includes brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), nerve growth factor (NGF), and ciliary neurotrophic factor (CNTF).

Mechanism of Action[edit]

Cerebrolysin works by mimicking the action of endogenous neurotrophic factors in the brain. It promotes neuronal survival, neurogenesis, and neuroplasticity, and it also has antioxidant and anti-apoptotic effects.

Clinical Use[edit]

Cerebrolysin is used in many countries for the treatment of Alzheimer's disease, stroke, and other neurological disorders. It has been shown to improve cognitive function and quality of life in patients with these conditions.

Side Effects[edit]

Common side effects of Cerebrolysin include headache, nausea, dizziness, and insomnia. In rare cases, it can cause allergic reactions.

Research[edit]

Research on Cerebrolysin has shown promising results in the treatment of Alzheimer's disease and stroke. However, more studies are needed to confirm its efficacy and safety.

See Also[edit]

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.